CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleLevered free cash flow is $238.98M, above the global median of $16.24M
- FinancialsAltman Z-Score 0.63: distress zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.62%Below 5Y avg (0.93%)
Annual Rate
CNY 0.03Paid annual
Payout Ratio
19.4%Sustainable
Last Ex-Dividend
Jul 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.35BCNY497.70M · vs all stocks (USD)
Trailing P/E
25.79xRevenue (TTM)
2.48BCNY368.82M · vs all stocks (USD)
Profit Margin
5.17%Beta
0.8590xvs all stocks
52-Week Change
-18.79%vs all stocks
Market Capitalization
3.35BCNY497.70M · vs all stocks (USD)
Enterprise Value
-2.03BCNY-301.40M · vs all stocks (USD)
Trailing P/E
25.79xPrice to Sales (TTM)
1.33xPrice to Book (MRQ)
0.7056xEnterprise to Revenue
-0.8170xEnterprise to EBITDA
-5.77xGross Margin
47.37%Profit Margin
5.17%Operating Margin
-5.09%Return on Assets (TTM)
0.74%Return on Equity (TTM)
4.23%Revenue (TTM)
2.48BCNY368.82M · vs all stocks (USD)
Revenue per Share (TTM)
3.69CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-15.00%Gross Profit (TTM)
786.58MCNY116.97M · vs all stocks (USD)
EBITDA (TTM)
556.38MCNY82.74M · vs all stocks (USD)
Net Income (TTM)
128.33MCNY19.08M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
78.30%Operating Cash Flow (TTM)
2.34BCNY348.28M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.61BCNY238.98M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0310CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
0.62%vs all stocks
5-Year Average Dividend Yield
0.93%vs all stocks
Payout Ratio
19.39%Minority Interest (Equity)
271.87MCNYFY2025 · Dec 31, 2025Revenue
2.52BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.70BCNYFY2025 · Dec 31, 2025Gross Profit
817.99MCNYFY2025 · Dec 31, 2025Operating Income
277.71MCNY41.30M · vs all stocks (USD)
Pre-tax Income
229.59MCNYFY2025 · Dec 31, 2025Income Tax Expense
81.39MCNYFY2025 · Dec 31, 2025Net Income
148.21MCNYFY2025 · Dec 31, 2025EBIT
373.87MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
547.24MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
454.11MCNYFY2025 · Dec 31, 2025Other Operating Expenses
94.51MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
10.52MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
144.28MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1004CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1004CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
673.40MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
673.40MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
148.21MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-80.60MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
877.14MCNYFY2025 · Dec 31, 2025Free Cash Flow
501.76MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
7.13BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
148.21MCNYFY2025 · Dec 31, 2025Other Non-cash Items
147.18MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-545.52MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
1.13BCNYFY2025 · Dec 31, 2025Capital Expenditures
-375.38MCNYFY2025 · Dec 31, 2025Net Acquisitions
1.09MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.59BCNYFY2025 · Dec 31, 2025Sale of Investments
1.80BCNYFY2025 · Dec 31, 2025Other Investing Activity
-45.05MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-207.82MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
435.12MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-942.03MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-189.69MCNYFY2025 · Dec 31, 2025Other Financing Charges
1.03BCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
337.18MCNYFY2025 · Dec 31, 2025Shares Outstanding
673.40MSharesUpdated Aug 20, 2026Float Shares
422.96MSharesUpdated Aug 20, 2026% Held by Insiders
45.76%vs all stocks
% Held by Institutions
10.40%vs all stocks
Total Cash (MRQ)
8.04BCNY1.19B · vs all stocks (USD)
Total Cash per Share (MRQ)
11.93CNYUpdated Aug 20, 2026Total Debt (MRQ)
2.51BCNY373.52M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5077xCurrent Ratio (MRQ)
1.19xBook Value per Share (MRQ)
6.94CNYUpdated Aug 20, 2026Total Assets
20.00BCNY2.97B · vs all stocks (USD)
Total Current Assets
14.03BCNYFY2025 · Dec 31, 2025Total Liabilities
15.19BCNYFY2025 · Dec 31, 2025Total Non-current Assets
5.98BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
3.31BCNYFY2025 · Dec 31, 2025Total Current Liabilities
11.88BCNYFY2025 · Dec 31, 2025Cash
1.59BCNYFY2025 · Dec 31, 2025Cash Equivalents
5.55BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
7.14BCNYFY2025 · Dec 31, 2025Other Short-term Investments
210.66MCNYFY2025 · Dec 31, 2025Accounts Receivable
30.54MCNYFY2025 · Dec 31, 2025Inventory
847.37MCNYFY2025 · Dec 31, 2025Accounts Payable
200.95MCNYFY2025 · Dec 31, 2025Short-term Debt
82.35MCNYFY2025 · Dec 31, 2025Other Current Liabilities
10.11BCNYFY2025 · Dec 31, 2025Long-term Debt
3.06BCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
97.83MCNYFY2025 · Dec 31, 2025Common Stock (Book)
673.40MCNYFY2025 · Dec 31, 2025Retained Earnings
2.58BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
4.81BCNY715.29M · vs all stocks (USD)
52-Week Low
4.29CNYUpdated Aug 20, 202652-Week High
7.62CNYUpdated Aug 20, 202652-Week Change
-18.79%vs all stocks
Beta
0.8590xvs all stocks
50-Day MA
4.76CNYUpdated Aug 20, 2026200-Day MA
5.94CNYUpdated Aug 20, 2026Avg 10-Day Volume
8.98MSharesUpdated Aug 20, 2026Avg 30-Day Volume
11.53MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.1900CNYUpdated Aug 20, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash Backing With OCF Coverage And Cash Near Total Debt
Cash on hand covers most or all of its total debt, and cash flow matches reported earnings.
Reads
How is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.47Profit Margin: 0.05
Financial Health
Altman Z-Score 0.63: distress zoneCritical
Altman Z-Score: 0.63
High earnings qualityNotable
Earnings Quality Score: 5.22
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Levered free cash flow is $238.98M, above the global median of $16.24MNotable
Levered free cash flow (USD): 238,978,959.145Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Beh-Property Co., Ltd.
Tier 1ProductionUnit ReplicationRiskRule
Chongqing Yukaifa Co., Ltd.
Tier 1ProductionUnit ReplicationRiskRule
HelloFresh SE
Tier 1ProductionUnit ReplicationFlowRule
Cccg Real Estate Corp Ltd.
Tier 1ProductionUnit ReplicationRiskRule
Greattown Holdings Ltd.
Tier 1ProductionUnit ReplicationRiskRule
Hangzhou Century Co., Ltd.
Tier 1ProductionUnit ReplicationFlowRule
Everbright Jiabao Co., Ltd.
Tier 1ProductionUnit ReplicationRiskFlow
El Pollo Loco Holdings Inc.
Tier 1ProductionUnit ReplicationInterfaceRule
DAP Gayrimenkul Geliştirme A.Ş.
Tier 1ProductionUnit ReplicationRiskRule
Hubei Fuxing Science & Technology Co., Ltd.
Tier 1ProductionUnit ReplicationRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Shanghai Shyndec Pharmaceutical Co., Ltd.
3 interpretationsClose Below 40W SMA With ProfitabilityPrice Below Mean With Profitability And Book ValueCash Backing With OCF Coverage And Cash Near Total Debt
Nky Medical Holdings Ltd.
3 interpretationsClose Below 40W SMA With ProfitabilityPrice Below Mean With Profitability And Book ValueCash Backing With OCF Coverage And Cash Near Total Debt
Sinomach General Machinery Co., Ltd.
3 interpretationsClose Below 40W SMA With ProfitabilityPrice Below Mean With Profitability And Book ValueCash Backing With OCF Coverage And Cash Near Total Debt